NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Brian D Lehmann
Vanderbilt University - Nashville / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4701224
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Brian D Lehmann's MOST POPULAR ARTICLES
1-)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesBD Lehmann, JA Bauer, X Chen, ME Sanders, AB Chakravarthy, Y Shyr, ...The Journal of clinical investigation 121 (7), 2750-2767, 201149662011
2-)
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceJA McCubrey, LS Steelman, WH Chappell, SL Abrams, EWT Wong, ...Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1773 (8), 1263-1284, 200726592007
3-)
Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selectionBD Lehmann, B Jovanović, XI Chen, MV Estrada, KN Johnson, Y Shyr, ...PloS one 11 (6), e0157368, 20169472016
4-)
Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypesH Masuda, KA Baggerly, Y Wang, Y Zhang, AM Gonzalez-Angulo, ...Clinical cancer research 19 (19), 5533-5540, 20138512013
5-)
Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targetsJM Balko, JM Giltnane, K Wang, LJ Schwarz, CD Young, RS Cook, ...Cancer discovery 4 (2), 232-245, 20145522014
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept